Clinical Trial Update: Clinical, Immunological, Morphological and Genetic Characteristics of Patients With Dysferlinopathy (LGMD R2) in the RF

View source ↗

Summary

A clinical trial in the Russian Federation is enrolling by invitation to study the immunological, morphological, and genetic characteristics of patients with dy…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dysferlinopathy
• Limb-girdle Muscular Dystrophy Type 2b
• Miyoshi Myopathy

Snippet

Sponsor: Artgen Biotech | Conditions: Dysferlinopathy, Miyoshi Myopathy | Status: ENROLLING_BY_INVITATION